Updated Jul 16, 2026
Struthers Richard Scott has filed 1 SEC Form 4 filing across 1 company in the last 90 days — selling. Lifetime open-market sales: $1.58M.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-02 | CRNX | Crinetics Pharmaceuticals, Inc. | G — Bona-fide gift | 111.1K | $0.00 | |
| 2026-06-02 | CRNX | Crinetics Pharmaceuticals, Inc. | G — Bona-fide gift | 111.1K | $0.00 | |
| 2026-06-02 | CRNX | Crinetics Pharmaceuticals, Inc. | G — Bona-fide gift | 111.1K | $0.00 | |
| 2026-06-02 | CRNX | Crinetics Pharmaceuticals, Inc. | G — Bona-fide gift | 111.1K | $0.00 | |
| 2026-06-02 | CRNX | Crinetics Pharmaceuticals, Inc. | G — Bona-fide gift | 111.1K | $0.00 | |
| 2026-06-02 | CRNX | Crinetics Pharmaceuticals, Inc. | G — Bona-fide gift | 111.1K | $0.00 | |
| 2026-06-02 | CRNX | Crinetics Pharmaceuticals, Inc. | G — Bona-fide gift | 111.1K | $0.00 | |
| 2026-06-02 | CRNX | Crinetics Pharmaceuticals, Inc. | G — Bona-fide gift | 111.1K | $0.00 | |
| 2026-06-02 | CRNX | Crinetics Pharmaceuticals, Inc. | G — Bona-fide gift | 80.0K | $0.00 | |
| 2026-06-02 | CRNX | Crinetics Pharmaceuticals, Inc. | G — Bona-fide gift | 222.2K | $0.00 | |
| 2026-06-02 | CRNX | Crinetics Pharmaceuticals, Inc. | G — Bona-fide gift | 222.2K | $0.00 | |
| 2026-06-02 | CRNX | Crinetics Pharmaceuticals, Inc. | G — Bona-fide gift | 80.0K | $0.00 | |
| 2026-06-02 | CRNX | Crinetics Pharmaceuticals, Inc. | G — Bona-fide gift | 222.2K | $0.00 | |
| 2026-06-02 | CRNX | Crinetics Pharmaceuticals, Inc. | G — Bona-fide gift | 222.2K | $0.00 | |
| 2026-03-18 | CRNX | Crinetics Pharmaceuticals, Inc. | S — Open-market sale [10b5-1] | 8.8K | $37.77 | $332K |
| 2026-03-18 | CRNX | Crinetics Pharmaceuticals, Inc. | S — Open-market sale [10b5-1] | 13.2K | $37.11 | $490K |
| 2026-02-25 | CRNX | Crinetics Pharmaceuticals, Inc. | A — Grant or award | 62.0K | $0.00 | |
| 2025-09-26 | CRNX | Crinetics Pharmaceuticals, Inc. | S — Open-market sale | 4.0K | $45.00 | $180K |
| 2024-12-04 | CRNX | Crinetics Pharmaceuticals, Inc. | S — Open-market sale [10b5-1] | 10.0K | $57.57 | $576K |
Struthers Richard Scott is a corporate insider — currently tracked as President & CEO, Director of Crinetics Pharmaceuticals, Inc. (CRNX). InsiderAlpha tracks every SEC Form 4 filing in real time.
1 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 4 open-market sales ($1.58M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Struthers Richard Scott profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.